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ABSTRACT
Thyrotoxic neuropathy is a rare entity in literature. The association between thyrotoxicosis and neuropathy is under-recognized. We 
here present a rare case report in which patient was presented with ascending sensory-motor paralysis coupled with respiratory muscle 
weakness which closely resembles Guillain–Barré syndrome (GBS). But relevant history suggested thyrotoxic features, thus a timely 
focused investigation revealed the diagnosis. It was confirmed in nerve conduction studies (NCS) and other necessary investigations 
ruled out other differential diagnosis. Patient was treated with anti-thyroid drugs. On follow up patient’s power improved and NCS 
after 6 months came out to be normal which established the diagnosis. Thyrotoxic neuropathy is a close differential diagnosis of 
LGBS and other commonly encountered neuroparalytic illnesses. So high degree of suspicion is needed to diagnose this potentially 
treatable neuropathy.
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Thyrotoxic neuropathy also known as Basedow’s Paraplegia [1] is rarely reported entity. It was described for the 1st time by Charcot in 1889 [2] and has not been very well-
recognized entity in literature. Various neurological diseases are 
associated with hyperthyroidism or thyrotoxicosis like myopathy, 
periodic paralysis with hyperthyroidism and hypokalemia, 
ophthalmoplegia and myasthenia gravis. The association between 
thyrotoxicosis and neuropathy is under-recognized. Though rare, 
thyrotoxic neuropathy is a treatable condition. It mimics very 
common diagnosis like Guillane Barre syndrome (GBS) thus 
a strong clinical suspicion is needed to establish the diagnosis. 
Here we present a case of 47-years-old female who was presented 
to our department with the complaint of weakness in bilateral 
lower limb. 
CASE REPORT
A 47-year-old female patient presented in the emergency with the 
complaint of weakness in bilateral lower limb for 1 day followed 
by weakness of bilateral upper limbs for 10 hours. The patient was 
well before she was presented with abrupt onset of weakness in 
bilateral lower limbs simultaneously. For initial few hours, patient 
could walk with support but had a weak grip of the floaters that 
she wore. After 12 hours of initial weakness, the patient became 
completely bed-ridden. She was unable to change posture on bed 
as well as sit up from supine position. Over next few hours, she 
felt her bilateral upper limb getting weaker initially in the form of 
holding cups followed by inability to comb her hair within hours. 
She experienced difficulty in raising head and had no drooping 
of eye lids. 
The weakness wasn’t followed by any high carbohydrate 
meal, fever, neck pain, diarrheal illness, vaccination, dog bite, 
neck trauma, nausea, vomiting or any history suggestive of raised 
intra cranial tension. Patient also complained of tingling sensation 
of bilateral feet and inability to perceive hot and cold temperature 
in bilateral legs upto knee. There was no history suggestive of any 
cranial nerve involvement, autonomic involvement, or any toxin 
exposure like mercury, arsenic. There was overflow incontinence. 
The patient didn’t give any past history of similar episodes 
though she suffered unintentional weight loss since last 5 months 
(from 62 kg to 47 kg in 5 months). The patient also experienced 
palpitation and chronic diarrhea for last 4 months. 
On examination, her vitals were normal with tachycardia 
(heart rate of 124 per minute, regular) and body mass index (BMI) 
15.3 Kg/m2. Higher mental functions were normal. Her Glasgow 
coma scale was 15/15 and Mini mental state examination of 
30/30. Examination of cranium, spine, and speech was normal. 
Examination of cranial nerves and autonomic nervous system 
was also normal Fig. 1. On sensory examination; pain, touch and 
temperature were impaired in lower limbs up to knee bilaterally. 
There was generalized areflexia with hypotonia. Power was 
0/5 bilateral lower limb, 2/5 bilateral upper limbs. There were 
no fasciculations and bilateral plantars were flexor. Patient 
was catheterized. Differential diagnosis kept was GBS, toxic 
neuropathy, human immunodeficiency virus (HIV) associated 
neuropathy, acute transverse myelitis .
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As there was bladder involvement possibility of GBS was 
slightly lower though there were typical ascending quadriplegia. 
Complete hemogram (hemoglobin 10.5 gm%; Total leukocyte 
count: 11500/uL with normal differential count; platelets: 276000/
uL), liver function tests (Bilirubin: 1.2 mg/dL, albumin: 4.1 g/dL, 
alanine transaminases: 35 U/L; aspartate transaminase: 43 U/L; 
alkaline phosphatase: 112 U/L) and renal function tests (urea: 
18 mg/dL; creatinine: 0.9 mg/dL) tests were normal including 
electrolytes (Sodium 135 mEq/L and Potassium 3.9 mEq/L). Her 
CPK was also normal 165 U/L (normal: 51-294 U/L).
Magnetic resonance imaging (MRI) cervical spine and 
NCS were done. MRI cervical spine was normal while that of 
NCS was suggestive of motor>>sensory predominantly axonal 
polyneuropathy. In view of tachycardia, unintentional weight 
loss and chronic diarrhea, thyroid function test were done which 
revealed high free T3 (64; normal - 3.7 – 6.5 pmol/L), and free T4 
(88; normal - 9-16 pmol/L) with suppressed TSH levels (0.001; 
normal - 0.34-4.25mIU/L).
Cerebro-spinal fluid (CSF) study after a week revealed no 
abnormality. There was no albumino-cytological dissociation 
while antinuclear antibodies (ANA), HIV 1/2, HbsAg and Anti 
HCV were negative. 
On day 2 of admission, patient had respiratory depression and 
her respiratory rate was 8/min and she was unable to maintain 
saturation. She was incubated and started on carbimazole (30 
mg twice daily), propranolol (60 mg 4 hourly). Patient clinically 
improved and was extubated on day five. Relevant investigations 
are detailed in table 1 and 2.
The patient was followed up in neurology OPD after she 
was discharged on anti-thyroid medications. On follow up after 
6 weeks, her power improved in all the 4 arms. Repeat NCS 
was done after 6 months which came out to be normal which 
accompanied normalization of free T3, T4 and TSH. It confirmed 
the final diagnosis of neuropathy associated with thyrotoxicosis. 
Nerve biopsy wasn’t done as patient didn’t give the consent for it.
DISCUSSION 
Thyroid hormone has an important role in early growth and 
development of a child. Hyperthyroidism is mainly associated 
with a thyroid adenoma or Grave’s disease, which would be 
accompanied by any other autoimmune illness. In addition 
to the physical symptoms associated with hyperthyroidism, 
a heterogeneous group of neuro -psychiatric symptoms and 
syndromes may occur [3,4]. Thyrotoxic periodic paralysis is not a 
very uncommon disorder that is manifested as recurrent episodes 
of hypokalemia and muscle weakness lasting from hours to 
days. This information is important as this clinical condition is 
particularly relevant to us in India, the incidence of the disorder is 
relatively higher among Asians [5]. 
Neuromuscular junction disorders like myasthenia gravis 
may be seen in a proportion of patients with hyperthyroidism. 
Patients with myasthenia gravis have an increased incidence 
of thyroid disorders; and 5.7% of myasthenic patients are 
found to be hyperthyroid [6]. Apart from these, in patients with 
hyperthyroidism, 80% have neuromuscular related complaints 
and more than half patients have marked muscle weakness [7]. 
Women predominate at 3:1 to 4:1, and the mean age of onset is 
fifth decade. Weakness is primarily proximal and is usually out 
of proportion to the amount of muscle wasting; distal weakness 
develops later and is less severe than the proximal myopathy. 
Myalgia, fatigue, and exercise intolerance are common. Rarely 
inflammatory myopathy may occur in thyrotoxicosis which 
necessitates corticosteroid therapy [8].
Thyrotoxic neuropathy or Basedow’s Paraplegia is a rarely 
reported entity. Its existence has often been questioned. Though 
cases with polyneuropathy and hyperthyroidism have been 
reported in literature [9,10]. The pathophysiology of neuropathy 
in hyperthyroidism is still obscure. It has been postulated to be 
either a direct effect of excessive thyroid hormones, immune-
mediated or due to a hypermetabolic state depleting the nerves of 
essential nutrients [11]. 
In our patient, we considered all the possibilities of acute lower 
motor neuron quadriparesis along with acute transverse myelitis 
Table 1: Motor Nerve Conduction Study
NERVE LEFT RIGHT 
Median Wrist elbow Wrist elbow 
Latency 3.5 (high)  7.8 4.2 8.7
Amplitude 6.0 2.6 1.4 (low) 1.5
Ulnar Wrist elbow Wrist elbow 
Latency 2.5 7.0 3.1 7.3
Amplitude 6.2 4.8 3.5 (low) 3.0
Perneal Ankle Fibula Head Ankle Fibula Head
Latency 8.7 13.7 4.1 9.6
Amplitude 180(low) 290 650 400
Tibial Ankle popliteal Ankle popliteal
Latency 4.5 13.4 4.0 11.8
Amplitude 1.7 (low)  900 4.3 3.8
Table 2: Sensory Nerve Conduction Study
Nerve Amplitude (µV) Right Left
Median 12.2 (low) 35.7( low)
Ulnar 22.5 (low) 38.4 (low)
Sural 6.7 (low) 3.2 (low)
Figure 1: normal MRI brain
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with spinal shock. GBS was ruled out according Brighton criteria 
and patient improved after successful treatment with carbimazole 
without plasmapheresis or intra venous immunoglobulin and her 
CSF was also normal. MRI cervical spine came out to be normal, 
serum electrolytes were also normal. Patient was negative for 
HIV1, & 2, CytoMegalo virus, Ebstein Barr virus, angiotensin 
converting enzyme and ANA. Her CPK and electromyography 
were normal. Finally, thyroid function test and antithyroid 
peroxidase antibodies and successful treatment with antithyroid 
drugs clinches the diagnosis. 
 A prospective study on hyperthyroid patients found that 
14% had numbness and paresthesia and 19% had signs of distal 
sensory disturbances in the limbs with depressed ankle jerks. 
Electrophysiological findings on them confirmed predominantly 
sensory axonal neuropathy among 24%; moreover, with treatment 
of the hyperthyroidism, the sensory symptoms resolved within 
seven months [11]. It has also been postulated that ‘thyrotoxic 
myopathy’ is actually a neuropathic disorder in its early stages 
of denervation. This has been shown by McComas et al who 
showed neuropathic changes in 20 patients with ‘thyrotoxic 
myopathy’ [12].
CONCLUSION
Thyrotoxic neuropathy is a close differential diagnosis of LGBS 
and other commonly encountered neuroparalytic illnesses. 
Though it is rare but it can be picked up by simple history talking 
and thyroid function tests and can be confirmed by NCS after 
ruling out common diseases. A high degree of suspicion is needed 
to diagnose this potentially treatable neuropathy. 
REFERENCE
1. Fiebel JH, Campa JF. Thyrotoxic neuropathy (Basedow’s paraplegia). 
J Neurol Neurosurg Psychiatry. 1976;39:491-7.
2. Charcot J. Nouveaux signes de la maladie de Basedow. Bull. Med. 
1889;3:147-9.
3. Loosen PT. Hormones of a hypothalamic-pituitary-thyroid axis: a 
psychoneuroendocrine perspective. Pharmacopsychiatr. 1986;19:401-15.
4. Demet MM, Ozmen B, Deveci A, Boyvada S, Adigüzel H, Aydemir O. 
Depression and anxiety in hyperthyroidism. Arch Med Res. 2002;33:552-6.
5. McFadzean AJ, Yeung R. Periodic paralysis complicating thyrotoxicosis in 
Chinese. BMJ. 1967;1:451-5.
6. Satoyoshi E, Murakami K, Kowa H, Kinoshita M, Noguchi K, Hoshina S 
et al. Myopathy in thyrotoxicosis: with special emphasis on an effect of 
potassium ingestion on serum and urinary creatine. Neurology. 1963;13:6.
7. Duyff RF, Van den Bosch J, Laman DM, van Loon BJ, Linssen WH. 
Neuromuscular findings in thyroid dysfunction : A prospective clinical and 
electrodiagnostic study. J Neurol Neurosurg Psychiatry. 2000;68:750-5.
8. Hardiman O, Molloy F, Brett F, Farrell M. Inflammatory myopathy in 
thyrotoxicosis. Neurology. 1997;48:339-41.
9. McComas AJ, Sica REP, McNabb AR, Goldberg WM, Upton ARM. 
Neuropathy in thyrotoxicosis. N Engl J Med. 1973; 289:219-20.
10. Fisher M, Mateer JE, Ullrich I, Gutrecht JA. Pyramidal tract deficits and 
polyneuropathy in hyperthyroidism, Combination clinically mimicking 
amyotrophic lateral sclerosis. Am J Med. 1985;78:1041-4. 
11. Duyff RF, Van den Bosch J, Laman DM, van Loon BJ, Linssen WH. 
Neuromuscular findings in thyroid dysfunction: A prospective clinical and 
electrodiagnostic study. J Neurol Neurosurg Psychiatry. 2000;68:750-5.
12. McComasa AJ, Sica REP, McNabb AR, Goldberg WM, Upton AR. 
Neuropathy in thyrotoxicosis. N Engl J Med. 1973;289:219-20.
Funding: None; Conflict of Interest: None Stated.
How to cite this article: Malakar S, Sharma KN, Rana A, Dutt K, 
Sharma T. Thyrotoxic neuropathy - a case report. Indian J Case Reports. 
2019;5(6):515-517.
Doi: 10.32677/IJCR.2019.v05.i06.003
